BNGO
(NASDAQ)
0.4833
+0.0044  (+0.92%)
Volume (24h): 1.99M Day Range: 0.4550 - 0.4898
Market Cap: 33.22M 52W Range: 0.2586 - 4.70
May-28-20 04:00PM What Makes Bionano Genomics, Inc. (BNGO) a New Strong Buy StockZacks
May-27-20 12:00PM Bionano to Participate in Maxim Group’s Covid-19 Virtual Conference Series: The Role of Cell Therapy and Clarity on TestingGlobeNewswire
May-19-20 12:00PM Cancer Genomics Consortium Members Demonstrate 100% Concordance Between Bionano Saphyr and Gold Standard Cytogenetics in LeukemiaGlobeNewswire
May-14-20 08:30PM Bionano Genomics to Report First Quarter 2020 Financial Results on June 18, 2020GlobeNewswire
May-04-20 09:00PM Bionano Genomics Adds Healthcare and Genomics Industry Experts with Experience in Commercialization and Reimbursement to Its Board of DirectorsGlobeNewswire
Apr-23-20 04:00PM Bionano Genomics, Inc. (BNGO) Upgraded to Buy: Here's WhyZacks
Apr-22-20 12:00PM Largest North American Site for FSHD Muscular Dystrophy Testing Adopts Bionano Genomics’ Saphyr for Majority of Clinical TestsGlobeNewswire
Apr-02-20 01:00PM BIONANO GENOMICS ANNOUNCES PRICING OF $18 MILLION UNDERWRITTEN PUBLIC OFFERINGGlobeNewswire
Mar-31-20 12:00PM Bionano Genomics to Support Largest Study to Date on COVID-19 Disease SusceptibilityGlobeNewswire
Mar-23-20 12:00PM Three Top European Sites Adopt Bionano Saphyr® for Cancer, Genetics, and Cytogenetic ApplicationsGlobeNewswire
Mar-10-20 12:00PM Bionano Genomics Will Be Used in Research Identifying Gene Variants that Contribute to Coronavirus Disease SusceptibilityGlobeNewswire
Mar-05-20 09:01PM Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business UpdateGlobeNewswire
Feb-28-20 09:01PM Bionano Genomics to Report Fourth Quarter and Year End 2019 Financial Results and Host a Conference Call and Webcast on March 5GlobeNewswire
Feb-24-20 01:00PM Bionano Genomics Releases Saphyr Updates for Industry-Leading Data Yields that Enable Analysis of Complex Cancer Samples at Unprecedented DepthsGlobeNewswire
Feb-21-20 01:00PM Bionano Genomics Data Drives Scientific Discoveries in Solid Tumors and Leukemias, To Be Presented at the 2020 AGBT ConferenceGlobeNewswire
Feb-10-20 01:00PM Bionano Genome Imaging Concordant with Traditional Cytogenetics in Landmark Leukemia StudyGlobeNewswire
Jan-10-20 01:00PM Users of Bionano Genomics’ Saphyr System to Present Reference Genome Assembly and SV Discovery for Plant and Animal Genomes at the PAG XXVIII ConferenceGlobeNewswire
Jan-06-20 01:00PM Bionano Genomics’ Saphyr® System is Adopted by GeneDx for the Clinical Detection of Genetic Variants in Muscular Dystrophies, Developmental and Reproductive DisordersGlobeNewswire
Dec-19-19 01:00PM Mayo Clinic Adopts Bionano Saphyr For Applications in Neurodegenerative DiseasesGlobeNewswire
Dec-05-19 04:56PM Benzinga Pro's Top 5 Stocks To Watch For Thurs., Dec. 5, 2019: KR, YETI, BNGO, GOOS, ULTABenzinga
01:00PM Breakthrough Findings in Leukemias Presented at ASH 2019 Demonstrate Bionano Saphyr’s Potential to Replace All Cytogenetic Methods and Show Additional Clinical UtilityGlobeNewswire
Nov-14-19 02:00PM Bionano Genomics, Inc. (BNGO) Upgraded to Buy: What Does It Mean for the Stock?Zacks
Nov-12-19 01:00PM Takeaways from AMP 2019 in Baltimore: Users of Bionano’s Saphyr System Presented Results from Multiple Studies Demonstrating the System’s Utility for a Variety of Disease IndicationsGlobeNewswire
Nov-07-19 09:01PM Bionano Genomics Reports Third Quarter 2019 Financial Results and Provides Business UpdateGlobeNewswire
12:18PM The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOsBenzinga
Nov-06-19 11:03PM Novogene Adopts Bionano’s Saphyr System Adding Saphyr’s Ultra-Sensitive and Ultra-Specific Structural Variation Detection to their Repertoire of ServicesGlobeNewswire
Nov-04-19 10:16PM Bionano Genomics to Report Third Quarter 2019 Financial Results and Host a Conference Call and Webcast on November 7GlobeNewswire
Oct-24-19 12:00PM Takeaways from ASHG 2019 in Houston: Users of Bionano’s Saphyr System Presented Validation Results for FSHD, Repeat Expansion Disorders and Digital Cytogenetics Among a Growing List of Applications of Saphyr in Human Genetics and Cancer ResearchGlobeNewswire
Oct-21-19 01:27PM Bionano Genomics Announces Pricing of $18 Million Underwritten Public OfferingGlobeNewswire
Oct-16-19 12:00PM Bionano Genomics Announces Adoption of Its Saphyr® System by Clinical Cytogenetics Groups in Academia and Industry to Replace Traditional Methods for Clinical TestingGlobeNewswire
04:12AM Top Researchers to Present Discoveries Made Possible by Bionano’s Saphyr System for Genome Imaging Technology at the ASHG 2019 Annual MeetingGlobeNewswire
Sep-20-19 11:46AM The Daily Biotech Pulse: FDA Approves Merck HIV Drugs, Five Prime CEO Quits, HTG Molecular Announces Secondary OfferingBenzinga
10:56AM What Kind Of Shareholder Owns Most Bionano Genomics, Inc. (NASDAQ:BNGO) Stock?Simply Wall St.
Sep-09-19 12:00PM Bionano Genomics to Present at the H.C. Wainwright 21st Annual Global Investment ConferenceGlobeNewswire
Aug-30-19 12:00PM Bionano Genomics Releases Users’ Video Presentations of Preliminary Data Affirming Saphyr's Potential to Replace Traditional Cytogenetics Methods in Certain Blood CancersGlobeNewswire
Aug-13-19 12:00PM Preliminary Data Confirm Saphyr’s Potential to Replace Traditional Cytogenetics Methods for Detection of Structural Variants in Certain Blood CancersGlobeNewswire
Aug-08-19 08:05PM Bionano Genomics Reports Second Quarter 2019 Financial Results and Provides Business UpdateGlobeNewswire
Aug-02-19 12:00PM Bionano Genomics to Report Second Quarter 2019 Financial Results and Host a Conference Call and Webcast on August 8GlobeNewswire
Jun-19-19 06:19PM How Much Are Bionano Genomics, Inc. (NASDAQ:BNGO) Insiders Spending On Buying Shares?Simply Wall St.
Jun-17-19 12:00PM Results Presented at ESHG 2019 Showcase the Advantages of Saphyr over Traditional Cytogenetics Methods for the Detection of Structural Variants in Patients with Genetic Disease and CancerGlobeNewswire
Jun-14-19 12:00PM Clinical Researchers Present Initial Results from Key Clinical Studies Designed to Evaluate the Performance of Saphyr® Against Traditional Cytogenetics Methods at the European Human Genetics ConferenceGlobeNewswire
Jun-13-19 12:00PM Leading Scientists and Clinicians Are Presenting Results From a Record Number of Studies at ESHG 2019 Showing How the Saphyr System From Bionano Genomics Provides Critical Insights Into Cancer and Genetic Disease and is Leading the Way to Digital CytogeneticsGlobeNewswire
Jun-12-19 12:30PM Bionano Genomics Appoints Kristiina Vuori, MD, PhD, to its Board of DirectorsGlobeNewswire
May-09-19 08:01PM Bionano Genomics Reports First Quarter 2019 Financial Results and Provides Business UpdateGlobeNewswire
May-03-19 12:00PM Bionano Genomics to Report First Quarter 2019 Financial Results and Host a Conference Call and Webcast on May 9GlobeNewswire
Apr-17-19 04:00PM Consortium Study Finds Bionano Genomics’ Optical Mapping Essential for Comprehensive Detection of Structural VariantsGlobeNewswire
Mar-18-19 12:00PM Bionano Genomics to Present at the 31st Annual ROTH ConferenceGlobeNewswire
Mar-12-19 01:17AM Bionano Genomics to Report Fourth Quarter and Fiscal Year 2018 Financial Results and Host a Conference Call and Webcast on March 14, 2019GlobeNewswire
Mar-06-19 09:01PM Bionano Genomics to Present at the Cowen and Company 39th Annual Health Care ConferenceGlobeNewswire
Mar-05-19 01:00PM The Largest Study Conducted with Bionano’s Platform to Date Reveals Never-Before-Seen Human Genomic Structural VariationsGlobeNewswire
Bionano Genomics, Inc. operates as a life sciences instrumentation company in the genome analysis space. The company develops and markets the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes, which is known as cytogenetics. Its Saphyr system comprises an instrument, chip consumables, reagents, and a suite of data analysis tools. The company's Bionano prep kits and labeling kits provide the critical reagents and protocols needed to extract and label high molecular weight DNA for use with the Saphyr system; and data solutions offering includes a suite of hardware and software for end-to-end experiment management, algorithms for assembling genome maps, and algorithms and databases for bioinformatics processing. It sells its instruments and consumables for research use applications primarily to laboratories associated with academic and governmental research institutions, as well as to pharmaceutical, biotechnology, and contract research companies in North America, Europe, the Middle East, India, Africa, and the Asia Pacific. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.
Stocks in other countries: United Kingdom India Canada Australia
Market Cap
Volume (24h)